Max Robotics — Global Service Robot Directory + US Certification

About

Ming-Li Hsieh is a urologic surgeon and researcher whose work centers on robotic-assisted surgery for prostate and kidney cancers, with a particular focus on improving functional outcomes and predicting disease progression. In a landmark 2022 study (18 citations), Hsieh demonstrated the clinical benefits of indocyanine green fluorescence during robot-assisted partial nephrectomy, showing how this intraoperative imaging technique can enhance tumor localization and reduce complications—a contribution that has helped refine nephron-sparing surgery. Hsieh also pioneered the use of extracorporeal magnetic innervation (ExMI) to treat postprostatectomy incontinence, a debilitating condition affecting quality of life; their 2015 trial (8 citations) showed that ExMI significantly increases functional bladder capacity and patient well-being. More recently, Hsieh has explored how body composition and pelvic fat distribution influence prostate cancer aggressiveness, using preoperative imaging to predict biochemical recurrence after robotic radical prostatectomy (2022, 7 citations). This work bridges surgical technique with personalized risk stratification, offering clinicians new tools for prognosis. Through these studies, Hsieh has established a reputation for advancing both the technical precision and the patient-centered outcomes of robotic urologic oncology.